## COO: The Cooper Companies, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 1.8% below STRENGTH zone (3.0-6.0%); PEG 2.14 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($78.15)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Insider Buying and Finance Shuffle Could Be A Game Changer For Cooper Companies (COO)**
- Source: Simply Wall Street | 20251219T153745 | Somewhat-Bullish | Relevance: 100%
- The Cooper Companies recently appointed Brian G. Andrews as principal accounting officer, coinciding with accelerated insider buying, notably by CooperVision President & CEO Albert G. White III. This leadership change and increased insider confidence are seen as positive signals, though the company's investment narrative still hinges on strong execution of its MyDAY contact lens initiative and managing market pressures for sustainable growth. Despite these efforts, investors should remain aware of potential challenges to free cash flow margins and increasing investment requirements.

**2. Insider Buying and Finance Shuffle Could Be A Game Changer For Cooper Companies (COO)**
- Source: Simply Wall Street | 20251219T150812 | Somewhat-Bullish | Relevance: 100%
- The Cooper Companies recently appointed Brian G. Andrews as principal accounting officer while insider buying, including a significant purchase by CooperVision President & CEO Albert G. White III, signals internal confidence. This comes as the company navigates a reliance on MyDAY execution for growth and manages pressure on free cash flow margins amidst rising investment needs. The company projects $4.9 billion revenue and $786.2 million earnings by 2028, with current valuations suggesting a potential 10% upside.

**3. The Cooper Companies (COO)'s Technical Outlook is Bright After Key Golden Cross**
- Source: Finviz | 20251219T170800 | Bullish | Relevance: 100%
- The Cooper Companies (COO) recently experienced a "golden cross" as its 50-day simple moving average surpassed its 200-day simple moving average, signaling a potential bullish breakout. Combined with a #2 (Buy) Zacks Rank and positive earnings estimate revisions, COO appears well-positioned for future gains. Investors are advised to monitor the stock for continued upward momentum.

**4. Taking Stock of Cooper Companies (COO) Valuation After CEOâ€™s Continued Insider Share Purchases**
- Source: Yahoo Finance | 20251218T120752 | Somewhat-Bullish | Relevance: 100%
- Cooper Companies (COO) has seen continued insider share purchases by its CooperVision CEO, Albert G III, suggesting confidence in the company. Despite a strong 90-day stock rebound, its valuation on current earnings is well above the industry average, posing a risk if growth falters. The narrative, however, suggests the stock is undervalued, targeting $90.50 due to anticipated free cash flow increases and debt reduction.

**5. Is Cooper Companies Fairly Priced After Recent Share Price Rebound?**
- Source: Simply Wall Street | 20251217T210804 | Neutral | Relevance: 100%
- Cooper Companies (COO) has seen a recent share price rebound, climbing 3.2% in the last week and 12.4% over the last month, driven by investor refocus on its core business areas. While a Discounted Cash Flow (DCF) analysis suggests the stock is trading at a slight discount, implying it's broadly in line with fair value, its Price-to-Earnings (PE) ratio indicates it's overvalued compared to industry averages. The article introduces "Narratives" as a way for investors to create personalized valuation models based on their assumptions for the company's future performance.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 10, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $88 | $72 | +22% |
| 2025-12-08 | Morgan Stanley | $83 | $76 | +9% |
| 2025-12-08 | Goldman Sachs | $71 | $64 | +11% |
| 2025-12-05 | Stifel | $95 | $85 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Neutral |
| 2025-12-08 | Morgan Stanley | main | Equal-Weight |
| 2025-12-08 | Goldman Sachs | main | Sell |
| 2025-12-05 | Stifel | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($1.04M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.2% (-1.1%)
- Blackrock Inc.: 7.8% (-0.8%)
- Capital World Invest: 5.4% (+25.7%)
- T. Rowe Price Invest: 5.0% (+33.2%)
- State Street Corpora: 4.4% (-0.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 10 raises (avg +14%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 2.14 elevated, pricing in significant growth expectations. Analyst sentiment positive (10 raises, avg +14%). Insider buying signal ($1.0M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.5B |
| Beta | 1.05 |
| 52W Range | $61.78 - $100.24 |
| Short Interest | 4.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.14 |
| Forward P/E | 16.7 |
| Current P/E | 18.4 |
| YoY Growth | 9.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 4.5% to 1.8% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.2pp (needs >3.0% for momentum thesis). MRS_5 (-0.3%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +SBN (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.76% (CS: 82) | Neutral |
| RSI_14 | 67.5 | Neutral |
| MACD Histogram | 0.18 | Bullish |
| vs SMA20 | 1.044x | Above |
| vs SMA50 | 1.111x | Above |
| vs SMA200 | 1.112x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $82.75
- **Stop Loss:** $78.15 (5.6% risk)
- **Target:** $87.35 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 260
- **Position Value:** $21,515.00
- **Portfolio %:** 21.52%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-03-05 (Est: $1.03)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.11 | $1.15 | +3.3% |
| 2025Q3 | $1.07 | $1.10 | +3.0% |
| 2025Q2 | $0.93 | $0.96 | +3.3% |
| 2025Q1 | $0.91 | $0.92 | +0.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*